Corporate Partnership

The European Society of Pathology (ESP) offers the ESP Corporate Partnership Program, bringing together leading pharmaceutical and diagnostic companies committed to advancing pathology across Europe. Through our Pharma and Diagnostic Corporate Partnerships, ESP welcomes industry innovators to join us in promoting excellence in pathology for optimal patient care. 

As the leading force in European pathology, ESP’s mission is to provide high-quality pathology diagnosis for all patients, deliver up-to-date education, and support pioneering research that translates science into clinical practice. By partnering with ESP, our corporate allies gain access to exclusive benefits, including participation in our annual Corporate Advisory Forum—a unique opportunity to explore advancements in diagnostics, digital pathology, biomarker testing, and more alongside ESP leaders. 

ESP is pleased to partner with visionary companies who share our mission and commitment to excellence. Explore the ESP Corporate Partners below and consider joining us to make a lasting impact in the field. 

Together with its partners, ESP is shaping a future of precision and excellence in pathology to benefit patients across Europe.